Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Beth Israel Deaconess Medical Center: Clinical Trials & FDA Approval Profile

Beth Israel Deaconess Medical Center (Global / Institutional) sponsors 41 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 18 active protocols (14 recruiting now), 16 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)17.1%
Median Closed Enrollment vs National (145 pts)47 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Beth Israel Deaconess Medical Center
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)41
Active Pipeline (Recruiting Now)18 (14)
Completed vs Stopped Early16 / 7 (17.1%)
Median Closed Actual Enrollment47 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Beth Israel Deaconess Medical Center
Hospital Research SiteLocationShared Protocols
Beth Israel Deaconess Medical CenterBoston, MA36
Massachusetts General HospitalBoston, MA5
Brigham and Women's HospitalBoston, MA4

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Beth Israel Deaconess Medical Center
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06066502Precision Ventilation vs Standard Care for Acute Respiratory Distress SyndromePhase IIIRECRUITING
NCT04093219PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical PatienPhase IIICOMPLETED

Explore interactive annual charts and M&A subsidiary rollups in the Beth Israel Deaconess Medical Center Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI